Mathias Préau-Moulinier

Mathias Préau-Moulinier's work experience includes their current role as an Auto-entrepreneur and founder of MPM Investissement, where they provide free investment-related content in various areas such as stock market, real estate, cryptocurrencies, and art. Mathias has been in this role since February 2022. Prior to this, they worked as a Consultant in Life Sciences - Qualification/Validation at Nalys from January 2021. Before that, they were a Consultant in Life Sciences - Qualification/Validation at AlisPharm from November 2019 to January 2021. Mathias also had a stage in Qualification/Validation at Catalent Pharma Solutions in Brussels, Belgium, from March 2019 to October 2019. Additionally, they conducted research experiments at the PEIRENE EA 7500 laboratory from April 2018 to May 2018, focusing on controlling the proliferation of colorectal cancer cell lines using Pofut1.

Mathias Préau-Moulinier completed their Bachelor's degree in Biology Health, with a specialization in Biochemistry, Molecular Biology, and Cell Genetics (BBMCG), at the Université de Limoges from 2014 to 2017. Mathias then pursued further education at the same institution, earning a Master's degree in Development of Health Products with a focus on Human Medicines and Medical Devices from 2017 to 2019. The field of study for their Master's degree is not specified.